|Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association|
LB Morgenstern, JC Hemphill III, C Anderson, K Becker, JP Broderick, ...
Stroke 41 (9), 2108-2129, 2010
|Closure of patent foramen ovale versus medical therapy after cryptogenic stroke|
JD Carroll, JL Saver, DE Thaler, RW Smalling, S Berry, LA MacDonald, ...
New England Journal of Medicine 368 (12), 1092-1100, 2013
|Practice Parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm:[RETIRED]: Report of the Quality Standards Subcommittee of the American Academy of …|
SR Messe, IE Silverman, JR Kizer, S Homma, C Zahn, G Gronseth, ...
Neurology 62 (7), 1042-1050, 2004
|Carotid artery diameter in men and women and the relation to body and neck size|
J Krejza, M Arkuszewski, SE Kasner, J Weigele, A Ustymowicz, RW Hurst, ...
Stroke 37 (4), 1103-1105, 2006
|2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert …|
GF Tomaselli, KW Mahaffey, A Cuker, PP Dobesh, JU Doherty, ...
Journal of the American College of Cardiology 70 (24), 3042-3067, 2017
|Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With the Guidelines–Stroke hospitals|
LH Schwamm, SF Ali, MJ Reeves, EE Smith, JL Saver, S Messe, DL Bhatt, ...
Circulation: Cardiovascular Quality and Outcomes 6 (5), 543-549, 2013
|Hematoma growth in oral anticoagulant related intracerebral hemorrhage|
B Cucchiara, S Messe, L Sansing, S Kasner, P Lyden
Stroke 39 (11), 2993-2996, 2008
|Prophylactic antiepileptic drug use is associated with poor outcome following ICH|
SR Messé, LH Sansing, BL Cucchiara, ST Herman, PD Lyden, SE Kasner
Neurocritical care 11 (1), 38-44, 2009
|Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH|
LH Sansing, SR Messe, BL Cucchiara, SN Cohen, PD Lyden, SE Kasner
Neurology 72 (16), 1397-1402, 2009
|Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack?|
BL Cucchiara, SR Messe, RA Taylor, J Pacelli, D Maus, Q Shah, ...
Stroke 37 (7), 1710-1714, 2006
|Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of …|
A Culebras, SR Messé, S Chaturvedi, CS Kase, G Gronseth
Neurology 82 (8), 716-724, 2014
|Stroke after aortic valve surgery: results from a prospective cohort|
SR Messé, MA Acker, SE Kasner, M Fanning, T Giovannetti, SJ Ratcliffe, ...
Circulation 129 (22), 2253-2261, 2014
|Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials: A Science Advisory From the American …|
PT O'Gara, SR Messe, EM Tuzcu, G Catha, JC Ring
Circulation 119 (20), 2743-2747, 2009
|Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study|
MK Tamura, D Xie, K Yaffe, DL Cohen, V Teal, SE Kasner, SR Messé, ...
Clinical journal of the American Society of Nephrology 6 (2), 248-256, 2011
|Why are acute ischemic stroke patients not receiving IV tPA?: Results from a national registry|
SR Messé, P Khatri, MJ Reeves, EE Smith, JL Saver, DL Bhatt, ...
Neurology 87 (15), 1565-1574, 2016
|Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter): Report of the Guideline Development, Dissemination, and Implementation …|
SR Messé, G Gronseth, DM Kent, JR Kizer, S Homma, L Rosterman, ...
Neurology 87 (8), 815-821, 2016
|Lipoprotein-Associated Phospholipase A2 and C-Reactive Protein for Risk-Stratification of Patients With TIA|
BL Cucchiara, SR Messe, L Sansing, L MacKenzie, RA Taylor, J Pacelli, ...
Stroke 40 (7), 2332-2336, 2009
|Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial|
SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ...
The Lancet Neurology 17 (12), 1053-1060, 2018
|Summary of evidence-based guideline: periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline …|
MJ Armstrong, G Gronseth, DC Anderson, J Biller, B Cucchiara, R Dafer, ...
Neurology 80 (22), 2065-2069, 2013
|Predictors of finding occult atrial fibrillation after cryptogenic stroke|
CG Favilla, E Ingala, J Jara, E Fessler, B Cucchiara, SR Messé, ...
Stroke 46 (5), 1210-1215, 2015